Epidermal Growth Factor Receptor Inhibitors and Antiangiogenic Agents for the Treatment of Non-Small Cell Lung Cancer

od Horn, Leora, Sandler, Alan
Izdano 2009

Emerging Data with Antiangiogenic Therapies in Early and Advanced Non–Small-Cell Lung Cancer

od Horn, Leora, Sandler, Alan B.
Izdano 2009

Angiogenesis in the Treatment of Non–Small Cell Lung Cancer

od Horn, Leora, Sandler, Alan B.
Izdano u Proc Am Thorac Soc (2009)

The Role of MET Receptor Tyrosine Kinase in Non-Small Cell Lung Cancer and Clinical Development of Targeted Anti-MET Agents

od Robinson, Kyle W., Sandler, Alan B.
Izdano 2013

Modeling and simulation of maintenance treatment in first-line non-small cell lung cancer with external validation

od Han, Kelong, Claret, Laurent, Sandler, Alan, Das, Asha, Jin, Jin, Bruno, Rene
Izdano u BMC Cancer (2016)

Phase III Clinical Trial Development: A Process of Chutes and Ladders

od Dilts, David M., Cheng, Steven K., Crites, Joshua S., Sandler, Alan B., Doroshow, James H.
Izdano 2010

Clinical Course of Advanced Non–Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4...

od Dahlberg, Suzanne E., Sandler, Alan B., Brahmer, Julie R., Schiller, Joan H., Johnson, David H.
Izdano 2010

A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596): A Trial of the Eastern...

od Horn, Leora, Bernardo, Patricia, Sandler, Alan, Wagner, Henry, Levitan, Nathan, Levitt, Mark L., Johnson, David H
Izdano 2009

C-reactive protein reduction post treatment is associated with improved survival in atezolizumab (anti-PD-L1) treated non-small cell lung cancer patients

od Patil, Namrata S., Zou, Wei, Mocci, Simonetta, Sandler, Alan, Ballinger, Marcus, Flynn, Susan, Kowanetz, Marcin, Hegde, Priti S.
Izdano u PLoS One (2021)

Prognostic Models to Predict Survival in Non-Small Cell Lung Cancer Patients Treated with First-Line Paclitaxel and Carboplatin with or without Bevacizumab

od Hoang, Tien, Dahlberg, Suzanne E., Sandler, Alan B., Brahmer, Julie R., Schiller, Joan H., Johnson, David H.
Izdano 2012

A Randomized Phase II Study of Carboplatin With Weekly or Every-3-Week Nanoparticle Albumin-Bound Paclitaxel (Abraxane) in Patients With Extensive-Stage Small Cell Lung Cancer

od Grilley-Olson, Juneko E., Keedy, Vicki L., Sandler, Alan, Moore, Dominic T., Socinski, Mark A., Stinchcombe, Thomas E.
Izdano u Oncologist (2015)

Phase II Study of Cisplatin Plus Etoposide and Bevacizumab for Previously Untreated, Extensive-Stage Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Study E3501

od Horn, Leora, Dahlberg, Suzanne E., Sandler, Alan B., Dowlati, Afshin, Moore, Dennis F., Murren, John R., Schiller, Joan H.
Izdano 2009

Sex Differences in Outcome with Bevacizumab Therapy: Analysis of Patients with Advanced-Stage Non-Small-Cell Lung Cancer Treated with or without Bevacizumab in Combination with Pac...

od Brahmer, Julie R., Dahlberg, Suzanne E., Gray, Robert J., Schiller, Joan H., Perry, Michael C., Sandler, Alan, Johnson, David H.
Izdano 2011

Retrospective Evaluation of the Clinical and Radiographic Risk Factors Associated With Severe Pulmonary Hemorrhage in First-Line Advanced, Unresectable Non–Small-Cell Lung Cancer T...

od Sandler, Alan B., Schiller, Joan H., Gray, Robert, Dimery, Isaiah, Brahmer, Julie, Samant, Meghna, Wang, Lisa I., Johnson, David H.
Izdano 2009

Body Mass Index and its Association with Clinical Outcomes for Advanced Non-Small Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials

od Dahlberg, Suzanne E., Schiller, Joan H., Bonomi, Philip B., Sandler, Alan B., Brahmer, Julie R., Ramalingam, Suresh S., Johnson, David H.
Izdano 2013

Development of Clinical Trials in a Cooperative Group Setting: The Eastern Cooperative Oncology Group

od Dilts, David M., Sandler, Alan, Cheng, Steven, Crites, Joshua, Ferranti, Lori, Wu, Amy, Gray, Robert, MacDonald, Jean, Marinucci, Donna, Comis, Robert
Izdano 2008

Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non–Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials

od Langer, Corey J., Socinski, Mark A., Patel, Jyoti D., Sandler, Alan B., Schiller, Joan H., Leon, Larry, Hazard, Sebastien J., Ramalingam, Suresh S.
Izdano u Am J Clin Oncol (2016)

Lung Cancer Survival Among Chinese Americans, 2000 to 2010

od Gomez, Scarlett Lin, Yang, Juan, Lin, Shih-Wen, McCusker, Margaret, Sandler, Alan, Patel, Manali, Cheng, Iona, Wakelee, Heather A., Clarke, Christina A.
Izdano u J Glob Oncol (2016)

Incidence Trends of Lung Cancer by Immigration Status among Chinese Americans

od Gomez, Scarlett Lin, Yang, Juan, Lin, Shih-Wen, McCusker, Margaret, Sandler, Alan, Cheng, Iona, Wakelee, Heather A., Patel, Manali, Clarke, Christina A.
Izdano u Cancer Epidemiol Biomarkers Prev (2015)

Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study

od Robert, Francisco, Sandler, Alan, Schiller, Joan H., Liu, Glenn, Harper, Karen, Verkh, Lev, Huang, Xin, Ilagan, Jennifer, Tye, Lesley, Chao, Richard, Traynor, Anne M.
Izdano 2009